On Monday, Shares of Nantkwest Inc(NASDAQ:NK), lost - 9.61% to $27.66.
NantKwest, declared the closing of its initial public offering of 9,531,200 shares of common stock at a price to the public of $25.00 per share, which comprised of 1,243,200 shares sold following the exercise in full by the underwriters of the offering of their option to purchase additional shares. NantKwest estimates the net proceeds from the offering were about $222.5 million after deducting the underwriting discounts and commissions and other offering expenses. Conpresently with the initial public offering, NantKwest also sold 680,000 shares of its common stock in a separate private placement to Celgene Corporation, an existing stockholder, at the initial public offering price, for additional proceeds of $17.0 million.
BofA Merrill Lynch, Citigroup Global Markets Inc., Jefferies LLC and Piper Jaffray acted as joint book-running managers for the offering, and MLV & Co. LLC acted as co-manager.
NantKwest, Inc., a biotechnology company, develops immunotherapeutic agents for various clinical conditions. It is initiating a Phase II clinical trial for its activated natural killer product candidate for the treatment of virally-induced cancers, such as polyomavirus induced Merkel cell carcinoma, human Papillomavirus, induced cervical cancer, and head and neck cancer, in addition to infectious diseases comprising Ebola and other viral, fungal, and bacterial infections.
Shares of Quanta Services Inc (NYSE:PWR), declined -0.72% to $27.42, during its last trading session.
Quanta Services, declared that it will release second quarter 2015 results on Wednesday, Aug. 5, 2015, before the market opens. In conjunction with the press release, Quanta has planned a conference call which will be broadcast live over the Internet on Wednesday, Aug. 5, 2015, at 9:30 a.m. Eastern time.
Quanta Services, Inc. provides specialty contracting services to the electric power, and oil and gas industries in North America and internationally. The companys Electric Power Infrastructure Services segment provides network solutions comprising design, installation, upgrade, repair, and maintenance of electric power transmission and distribution infrastructure, and substation facilities.
At the end of Monday’s trade, Shares of Dover Corp (NYSE:DOV), lost -2.04% to $62.76.
Dover, declared that it has reduced its forecast for 2015 full-year revenue and diluted earnings per share from ongoing operations (“EPS”).
The Company now anticipates full-year revenue to decline -8% to -9% as compared to a preceding revenue forecast of -4% to -6%. This revised forecast comprises organic revenue of -7% to -8%, a -4% impact from foreign currencies, and growth from accomplished acquisitions of 3%. The primary factors driving this revision are continued weak fundamentals in the North American oil & gas markets, and generally weaker capital spending in retail refrigeration and certain industrial end-markets. Full-year EPS is now anticipated to be in the range of $3.75 - $3.90, as contrast to its preceding guidance of $4.20 - $4.40. This new forecast represents a $0.50 reduction to the high-end of the preceding guidance and a $0.45 reduction to the low-end.
Dover Corporation manufactures and sells a range of equipment and components, specialty systems, and support services in the United States. The company operates in four segments: Energy, Engineered Systems, Fluids, and Refrigeration & Food Equipment.
Finally, Centene Corp (NYSE:CNC), ended its last trade with 1.20% gain, and closed at $70.97.
Centene Corporation, declared its financial results for the quarter ended June 30, 2015. The following talk aboutions, with the exception of cash flow information, are in the context of ongoing operations.
Michael F. Neidorff, Centene’s Chairman and Chief Executive Officer, stated, “Our strong second quarter results offer further evidence of Centene’s positive financial and operating momentum. Our pending Health Net acquisition will enhance our long-term growth opportunities by adding greater product diversity and scale.”
Centene Corporation operates as a diversified, multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates in two segments, Managed Care and Specialty Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
